Health committee  I would agree with that. Yes. As I said earlier, we can be quite sophisticated about stockpiling. We have to look at all the inputs. It's not just the fill and finish of the tablet and the drug itself; there's the active pharmaceutical ingredient, mostly sourced from India and C

Health committee  That's correct.

Health committee  That is also correct.

Health committee  Particularly for IV drugs, which form the bulk of our critical drugs, that is correct.

Health committee  Generally speaking, it has gone down. If we dive into the weeds of it, we are quite vulnerable for IV medications, which, again, form the bulk of our critical medications in a hospital.

Health committee  That's correct.

Health committee  Absolutely. I do think that when it comes to critical medications, we're seeing exactly what happens. We're seeing people going to emergency departments to get their hands on pediatric formulations of Tylenol. We saw shortages of key anaesthetics that I use in emergency care and

Health committee  Thank you for having me. Dear honourable members, in the context of the committee's urgent study on the shortage of pediatric acetaminophen formulations, and on behalf of the Critical Drugs Coalition, which is a non-partisan and grassroots coalition of frontline physicians, phar

Finance committee  We've actually had some really good studies done in the U.K., to answer this question. There is a generic steroid, dexamethasone, that is being routinely used. Then there is a newer medicine. It's a biologic medicine and it's quite expensive—tocilizumab. It took me a while to l

Finance committee  It hasn't really been shown to be beneficial in the research that I've seen so far. The research was mainly based on the trials out of the U.K., where because of the NHS they were able to do really cool studies where you just had hundreds of thousands of patients enrolled in diff

Finance committee  Thank you.

Finance committee  No, I'd have to look that up.

Finance committee  It certainly is, and I would say that at the beginning of the pandemic we were ventilating more. As we have learned how to deal with COVID-19 and the particular use of some of the therapeutics that have come up—there are all sorts of new medicines that we've found are helpful—we

Finance committee  We've had many warning signs. It's been going on for over a decade. In 2012, there actually was a fire in the one plant we have in the country that makes the injectables. That caused massive shortages at that point. There was a similar kind of inquiry and other doctors spoke abou

Finance committee  For sure, I think it is an interesting proposal that could really increase harmonization in regulations. That's a huge cost for a lot of generic drug companies, dealing with multiple regulatory barriers, paperwork, red tape and stuff. Crossing that can be quite a cost.